Zantac® Injury Lawyer

Zantac Cancer Lawyer

Houston Zantac Cancer Lawyers

Update: As of September 14, 2022, the MDL registry was closed.

Thousands of  Zantac lawsuits are pending in the Zantac MDL filed in the United States District Court for the Southern District of Florida alleging the presence of excessive amounts of NDMA in Zantac caused user’s cancer. If you or a loved one has developed cancer following a three-month continuous use of Zantac®, you should consult a Zantac Cancer lawyer.  You may be entitled to legal compensation for your damages. Call 1-800-298-0111 to get connected to a Zantac Cancer Lawyer today.

What Types of Cancer Qualify for the Zantac MDL?

The five types of cancer that qualify for the Zantac MDL are:

  • Esophageal cancer
  • Liver cancer
  • Bladder cancer
  • Pancreatic cancer
  • Stomach cancer.

Other cancers have been alleged to be linked to Zantac, however, the plaintiff’s steering committee has elected not to pursue other types of cancers due to causation issues. Other law firms may pursue these in State courts outside of the MDL.

What is Zantac?

Zantac is the brand name for the antacid drug Ranitidine Hydrochloride.  It is commonly used to treat heartburn, indigestion, peptic ulcers, acid-reflux disease a/k/a/ GERD,  Zollinger-Ellison syndrome, and to prevent ulcers.  Zantac has been available since the 1980s. It may be obtained by prescription or purchased over the counter.

Why Was Zantac Recalled?

On April 1, 2020, The FDA announced that they were sending letters to all manufacturers of Zantac requesting that they withdraw Zantac from the market entirely and advising consumers to stop taking the drug immediately as a result of the discovery that Zantac not only contains a known carcinogen, N-nitrosodimethylamine (NDMA) but also that the levels of NDMA in Zantac increase over time with normal storage of the product.  NDMA is a known carcinogen–a substance that can cause cancer when you are exposed to certain levels.  The FDA noted that NDMA levels increase as Zantac is stored under typical storage conditions but that it goes up even more when stored under hotter conditions such as in warehouses or non-air-conditioned rooms.

What is N-Nitrosodimethylamine?

N-Nitrosodimethylamine (NDMA) is a byproduct of many industrial manufacturing processes, including the manufacturing of unsymmetrical dimethylhydrazine, which is a component of rocket fuel that requires NDMA for its synthesis. It is classified as a B2 carcinogen–meaning it is known to cause cancer in animals and a probable cause of cancer in humans. This is the same agent that is fueling the Valsartan lawsuits. Trace amounts can be found in some foods but are generally not believed to be harmful. The FDA will allow trace amounts up to 96 nanograms in drugs meant for human consumption.

Does Zantac Contain NDMA?

A trace amount of NDMA is expected to be found in Zantac as in many drugs. However,  the NDMA levels are problematic in Zantac for two reasons: First, the NDMA levels tend to increase over time as the product is stored. Second, Valisure’s tests suggest the NDMA levels elevate when Zantac hits the stomach fluid containing nitrate—a compound formed from nitrogen and oxygen. Nitrate is found in certain foods, particularly processed meats. These two problems for the basis of the Zantac class-action lawsuits.

History of the Investigation into Zantac

On September 9th, 2019, a company called Valisure petitioned the FDA to order a voluntary recall of Zantac. Valisure is an online pharmacy that boasts analyzing each batch of medicine before it distributes to consumers. They are effectively the whistleblower in this class action.  Their tests suggested that Ranitidine can react with itself under certain conditions resulting in the production of NDMA at levels extremely higher than the FDA-allowable daily intake limit of 96 nanograms. “Valisure has detected NDMA in excess of 3,000,000 nanograms per tablet…likely due to an inherent instability in the ranitidine molecule,” according to their petition.

On October 2, 2019, the FDA reported finding “unacceptable levels” of NDMA in some samples tested.  Since the FDA’s finding, several manufacturers including GlaxoSmithKline and Sanofi have instituted voluntary recalls while the FDA investigates Valisure’s findings. Upon this discovery, many retailers of the product began pulling it from the shelves at that time. The FDA’s ongoing investigation has now determined that the NDMA levels rise over time as the product is stored, particularly if stored in higher temperatures.

Talk to a Texas Zantac Cancer Lawyer

If you have developed cancer after three months or more of taking Zantac or its generic equivalents, you may have a case. We are currently  interested in evaluating cases involving:

  • Three months or longer of regular use prior to the diagnosis of one of the listed cancers, and;
  • Took brand name Zantac in any state except Michigan, OR
  • Took generic Zantac in California, Illinois, Massachusetts, or Vermont.

Other Zantac lawsuit attorneys may set different criteria. If you believe you may qualify for the Zantac class-action lawsuit under the above criteria, call Simmons and Fletcher, P.C. to get connected with a Zantac cancer lawyer in Texas today.

*We associate with other counsel for the handling of some product liability claims. Thus, some cases may be referred to other counsel, and/or other counsel may be associated for the combined handling of claims with the client’s consent.

Warning: Do not stop taking a prescribed medication without first consulting a physician.

Author